A double blind, placebo-controlled study showed that patients using topical fluridil had an increase in the anagen to telogen ratio, and the maximum attainable effect was achieved within the first 90 days of daily use
GLP-1s are ideal for people who: Have a BMI of 27+ (with a medical condition) or 30+ Have tried and failed at traditional diet/exercise plans Want a medical, non-surgical approach Are experiencing weight gain due to hormonal shifts, stress, or emotional eating Contraindications include: Personal or family history of medullary thyroid carcinoma (MTC) History of Multiple Endocrine Neoplasia syndrome type 2 (MEN2) History of pancreatitis Pregnancy, breastfeeding or planning to conceive (uncertainty due to limited human studies) Type 1 diabetes (these meds are not approved for this condition) GLP-1 medications are not appropriate for everyone
But inclusion on the formulary does not mean automatic approval
She points to GLP-1 weight loss peptides, which "went from niche diabetes medications to transforming how we think about obesity and metabolic disease." "Peptide therapies could follow a similar trajectory, but only if they go through the rigorous human trials that the GLP-1s did," she said
Onceweekly dulaglutide versus oncedaily liraglutide in metformintreated patients with type 2 diabetes (AWARD6): a randomised, openlabel, phase 3, noninferiority trial
For complete regulatory framework coverage, see Are Peptides Legal in Canada
